返回 Agenda
Session Chair(s)
Yi Feng
SVP, Medical and Reg Affairs
Fountain Medical Development Ltd., China
Speaker(s)
GLP Excellence and Impact on Regulatory Review and Approval
Dylan YAO, MD, PHD
Joinn Laboratories, Inc., China
Senior Vice President and CSO
GLP Excellence and Impact on Regulatory Review and Approval
Representative Invited
EFRP, Egypt
Biologics - Device Reviewer’s Perspective on the GMP
Gang Wang, PHD
U.S.FDA China Office, China
TFDA Current and Future Directions
Lih-Jiuan Hsu
Center for Drug Evaluation, Taiwan, Taiwan
Deputy Executive Director